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Death After Transplantation 
An Analysis of Sixty Cases 
T ISSUE transplantation has become a widely practiced mode of therapy for chronic 
disease of a variety of organs. When the trans- 
planted tissue has minimal antigenic capacity, 
when its antigens are similar to those of the 
recipient, when viability is not required for suc- 
cess, or when the graft is protected from the 
host, success in transplantation has been readily 
achieved for many years. Homotransplants of 
bone, cornea and portions of vessels are in this 
category, as are isogeneic grafts in which tissue 
is simply moved from one site to another in the 
same person. Identical twins likewise have identi- 
cal antigens and can readily reciprocate tissues. 
However, transplantation for replacement of 
major organs has posed major difficulties. 
Some of the technical problems in the trans- 
plantation of major organs were worked out a 
number of years ago when kidney homotrans- 
plantation between identical twins was achieved 
[ I ] .  With a deeper understanding of immuno- 
logic mechanisms, and particularly with the 
discovery of methods for variable attenuation 
of the immune response [ Z ] ,  it became theoreti- 
cally possible to control immunologic rejection 
of transplanted organs. Major achievements in 
this regard have been reported in animals. 
Attempts i n  man have met with varying but 
encouraging degrees of success [3] .  
Attempts have been made to transplant a 
variety of functional organs [4] but substantial 
success in prolonging useful life through such 
procedures has been limited to kidney trans- 
plantation. In analyzing the data that have 
become available in the past four years it has 
become clear that the problem of suppressing 
the host's immune response has by no means 
been conquered, and current efforts are aimed 
at  providing closer antigenic matches between 
donor and recipient [5] .  Meanwhile, the most 
effective treatment continues to be immuno- 
suppression with drugs and radiation. 
This communication is an analysis of the 
causes of death among patients who have re- 
ceived kidney, liver and spleen grafts at the 
University of Colorado Medical Center and 
Denver Veterans Administration Hospital. I t  
is suggested that in selected cases a pernicious 
yet unavoidable chain of events ensue early in 
the postoperative period, viz., a violent immuno- 
logic reaction on the part of the recipient neces- 
sitating correspondingly vigorous immunosup- 
pression which so damages the host's defense 
mechanisms that he is unable to resist infestation 
by ambient or saprophytic organisms, to which 
he often succumbs. Patients in whom this chain 
of events never begins have a relatively favor- 
able prognosis, but when there is an early and 
continued need for a high level of steroid therapy 
and immunosuppression, the patient predictably 
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TABLE I 
MORTALITY I N  TRANSPLANT RECIPIENTS 
(123 PATIENTS) 
Mor- 
Patients Deaths tality 
Data (no.) (no.) (7%) 
Kidney homotransplants 
Related live donor 
Unrelated live donor 
Cadaver donor 










NOTE: Data include all fatalities. All subsequent 
tables include only the sixty patients examined at autopsy 
at the University of Colorado Medical Center and 
Denver Veterans Administration Hospital. 
will have a protracted and difficult course, al- 
though death or graft failure may be delayed for 
months or years. 
From the start of the program in human organ 
transplantation at  this Center in March 1962, 
through December 1965, 123 patients received 
organ transplants. The program was separated 
into two phases by a hiatus of six months (March 
through September 1964) for evaluation of 
results. Included are 11 3 kidney transplants, 
of which sixty-four were from living related 
donors, thirty-five from living unrelated donors, 
six from cadaver donors, six from baboons and 
two from identical twins. In addition, there were 
seven liver homotransplants in patients with 
hepatoma or liver failure due to cirrhosis, and 
spleen homotransplants in three patients with 
metastatic carcinoma. As of March 31, 1966, 
sixty-five patients had died at from zero to 930 
days after surgery. Five patients died elsewhere 
and their data are not included in this report. 
Methods of selection of patients, operative 
details and postoperative care have been pub- 
lished elsewhere [6]. I t  is worth emphasizing, 
however, that all had terminal disease and that, 
with the exception of the grafts in identical 
twins, adjunctive and postoperative treatment 
included splenectomy (with the exception of two 
patients), azathioprine, prednisone, thymec- 
tomy in selected cases, and often actinomycin 
C and local radiation of the kidneys. The dose 
of azathioprine was adjusted in general so that 
leukocytosis was suppressed and a normal white 
blood cell count was maintained. I'rednisone 
was used at the dose level required to suppress 
evidence of immunologic intolerance of the 
graft, and actinomycin C and local radiation 
were employed adjunctively during periods ot 
rejection crisis. Following the moratorium 
(October 1964), a slightly different therapeutic 
approach was adopted which included utiliza- 
tion of prospective antigen matching of the 
donor-recipient pairs [7] and a more conserva- 
tive use of azathioprine. The two identical 
twins received no immunosuppressive therapy. 
Whenever clinical infection became apparent, 
antimicrobial agents were administered in most 
cases according to the type of organism recog- 
nized. In some cases brief therapy with methi- 
cillin was given at the time of surgery in order 
to prevent staphylococcal wound infections. 
Other drugs included, when necessary, po- 
tentially nephrotoxic agents such as poly- 
myxin-B and kanamycin. 
At autopsy, routine procedures for culture, 
dissection, and preparation of tissues were 
employed. Periodic acid-Schiff, methenamine 
silver, Giemsa, Brown and Brenn, and Ziehl- 
Neelsen stains were employed for the demon- 
stration of microorganisms in tissue sections 
and occasionally in smears. 
The over-all mortality was 53 per cent, 
but the survival rate in patients receiving grafts 
from close relatives was approximately twice 
that in patients who received their grafts from 
unrelated donors (Table I). The identical twin 
recipients are both living and well. 
In the group of sixty-two patients given trans- 
Cause of Death 




















*Zero to twenty-four days after surgery. 
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plants prior to March 1964, fourteen deaths 
occurred during the first twenty-four post- 
operative days. Early deaths were much less 
common during the next twenty-five months, 
only two occurring in sixty-one patients. 
Causes of early death are listed in Table 11. 
I t  is apparent that two thirds of these resulted 
from general postoperative complications and 
one third were related to immunologic or in- 
fectious complications. considerable improve- 
ment in the incidence of postoperative com- 
plications is manifest. 
By contrast, among the forty-four patients 
who died twenty-five days or more after surgery, 
death was clearly related to infection in thirty- 
eight (86 per cent) (Table 111). Multiple in- 
fections were common (Table IV). The or- 
ganisms responsible for late infections are for 
the most part opportunistic rather than common 
pathogens. For instance, infections with gram- 
positive pyogenic organisms (staphylococcus, 
streptococcus and pneumococcus) were rarely 
recorded. The virtual absence of this latter 
group almost certainly reflects their relative 
ease of identification and their susceptibility 
to antibiotic therapy. The organisms responsible 
for fatal infections in these patients are, by 
and large, difficult to deal with under the best 
circumstances. Infection with pseudomonas, no- 
cardia and fungi accounted for a substantial 
majority (73 per cent) of deaths. 
In contrast to the diminution in the early 
death rate noted during the second phase, the 
late death rate (due to sepsis) has not decreased. 
Among the sixty-two patients who received grafts 
before February 1964, fourteen of eighteen late 
deaths (78 per cent) were due to septic complica- 
Patients 










* More than twenty-four days after surgery. 
t Five patients were assigned two causes of death. 
TABLE IV 
ORGANISMS RECOVERED AT AUTOPSY (SIXTY PATIENTS) 
Cause of Ancillary 
Death Infection 
Organism (no. (no. ) 
Pseudomonas 















tions.There have been thirty-one late deaths since 
then in a population of eighty-nine, which in- 
cludes survivors from the original series plus 
patients operated on since then. Five of these 
died elsewhere; twenty-three of the remainder (88 
per cent) died of infection. Among this group of 
eighty-nine subjects fifty-eight are living, thirty- 
three of whom have survived longer than twenty- 
four months. 
Cytomegalovirus and Pneumocystis carinii 
were found with extraordinary frequency. 
Pneumocystis was identified in nine patients,* 
although in only two of these was pulmonary 
insufficiency secondary to the parasitic infection 
believed to be the primary cause of death. 
Despite the frequency of cytomegalovirus found 
in the lungs and elsewhere in thirty of the pa- 
tients in this group (50 per cent), the virus did 
not appear to be a cause of death in any case. 
Details of these infections have been published 
elsewhere [8,9]. 
Fungal infections were also frequent [TO]. 
The pathogens most commonly found were 
candida and aspergillus, but histoplasma and 
nocardia were also seen. Double fungus in- 
fections were observed three times and bacterial 
infection often was present coincidentally. 
Comparison of .the survival times of patients 
who died of noninfectious causes with those of 
patients who died with pseudomonas, fungus 
* A  tenth case was reportedly found at autopsy else- 
where. 
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*--a All  deaths 
a---o Pneumocyrtis deaths 
- Non-infectious deaths 
- Pseudomonar deaths 
a--a Fungus deoths 
DAYS OF SURVIVAL 
FIG. 1. Per cent survival with time among fatalities, according to cause of death. 
Noninfectious deaths are virtually nonexistent after fifty days; rate of death from fungus 
and pseudomonas closely approximates the overall death rate, but deaths with pneumo- 
cystis infection occur appreciably later. 
or pneumocystis infection shows clearly that 
noninfectious death is an early event, fungi and 
pseudomonas cause death at a rate which ap- 
proximates that of the over-all death rate, and, 
significantly, pneumocystis becomes an im- 
portant factor only at an appreciably later time 
(Fig. 1). 
The anatomic characteristics of the infections 
were those which might be expected in patients 
with poor defense mechanisms and, in many 
cases, depressed bone marrow function [I?]. 
~ r e ~ u e n t l ~ ,  the growth of organisms and their 
necrotizing effects seemed virtually unopposed 
by the host. Large foci of necrosis with abscesses, 
little evidence of granulation tissue response, 
massive fungus proliferation, widespread "selec- 
tive vasculitis" [I21 and poor or absent poly- 
morphonuclear response were the rule. Al- 
though the infections were most commonly 
pulmonary, peritonitis, pyelonephritis with ab- 
scesses, meningitis and encephalitis were also 
encountered. Specific effects of toxic antibiotics 
were not recognized. 
One patient, mentioned previously [I  I], 
died of hemorrhagic pancreatitis without evi- 
dence of infection other than cytomegalovirus 
eighty-three days after receiving a transplant. 
Another patient who died 665 days after trans- 
plantation had severe pancreatitis in addition 
to multiple infections including aspergillosis, 
pneumocystis pneumonia, cytomegalovirus in- 
fection and an unidentified sporozoon in the 
liver, peripancreatic fat and heart. Many other 
patients were found to have varying degrees of 
nonhemorrhagic pancreatitis at autopsy. Al- 
though occasional small fat emboli were ob- 
served in some cases, this was not found to be the 
cause of death in any case, and in every instance 
the emboli were so minor as to be considered 
insignificant. Fat embolism has been reported 
to be a cause of death in transplant recipients 
[13]. Small pulmonary thromboemboli were 
common, but appeared to be associated almost 
exclusively with early death. 
Renal failure was only rarely considered to 
be the prime cause of death. This statement 
does not ignore the fact that an appreciable 
percentage of those who died had poor renal 
function prior to or at the time of death. Since, 
in the absence of significant infections or other 
lethal complications, these episodes are fre- 
quently successfully managed by adjustment of 
drug dosage, radiation, dialysis or retransplanta- 
tion, poor renal function alone seldom was con- 
sidered to have caused death. It must be pointed 
out, in addition, that the majority of patients 
had good renal function at the time of death, 
with normal or near-normal blood urea nitrogen 
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and other function tests, and histologic study 
of the transplanted kidneys in these cases re- 
vealed relatively normal histological findings 
except in those who had survived for a long time 
in whom obliterative vascular changes often 
were apparent [74,15]. 
As homotransplantation of whole organs 
moves out of the era of tentative and somewhat 
heroic experimentation, as understanding of 
the scientific basis of graft rejection accumulates, 
and as day-to-day experience with transplant 
technic is gathered, it becomes possible to an- 
alyze the causes of failure with a view toward 
correcting them. The two outstanding facts 
that emerge from this study are (1) death in 
the first three weeks after surgery has become 
a relatively rare event, and (2) later death is 
nearly always due to infection which, at present, 
eludes effective therapy, and the cause of which 
is to be found early in the patient's course. 
In the first sixty-two patients given transplants 
at  these institutions nearly 20 per cent died in 
the first twenty-four days, with such contributory 
causes of death as pulmonary embolus, non- 
functioning graft and electrolyte imbalance 
(Table 11). The deaths included four patients 
who received liver transplants and two with 
kidneys transplanted from simian donors. With 
increased understanding of immediate post- 
operative complications, and with more selective 
choices of donors and recipients, the early 
mortality was reduced in the next sixty-one 
patients to only two patients: one suffered a 
myocardial infarct, the other died of Pseudomo- 
nas septicemia. Thus it seems clear that tech- 
nical problems related to the surgery itself as 
well as complications arising during the early 
postoperative period have been minimized. 
On the other hand, late infection remains an 
unconquered problem. Seventy-eight per cent 
of late deaths in the first series of patients, and 
88 per cent in the second series resulted from 
intractable infection. I t  appears most likely 
that the immediate cause is the damage to host 
defense mechanisms which must be inflicted 
to achieve graft tolerance. The events leading 
ruthlessly to this damage occur within the first 
weeks after surgery; those patients whose early 
need for prednisone and immunosuppression is 
high and remains high are the ones who will 
subsequently succumb to infection. 
I t  now seems generally agreed that therapy 
with antimetabolites and adrenal corticoids 
in large doses alters the patient's metabolism, 
thus rendering him more vulnerable to in- 
fection [4,11]. Infection may be due to or- 
ganisms which are ordinarily pathogenic, ubiq- 
uitous nonpathogens, saprophytes or potentially 
pathogenic organisms commonly present in 
subinfecting quantities. To a considerable 
extent the mechanisms involved in antin~icrobial 
defense are depressed pari passu with those in- 
- .  
volved in foreign organ graft rejection; de- 
pression of one will therefore adversely affect 
the other. Some patients are unable to tolerate 
their grafts as well as others and therefore 
require more therapy; thus, they suffer more 
severe damage to their defense mechanisms. 
These patients are ultimately unable to with- 
stand the onslaught of microbial infestation. 
- 
If infections with ordinary pathogens are ar- 
rested in these patients with antibiotics therapy, 
pseudomonas or fungus infections develop. If 
they avoid these organisms, they eventually 
fall prey to pneumocystis (Fig. 1). The change 
in therapy since October 1964 has not signifi- 
cantly altered this late mortality due to in- 
fection despite the use of smaller doses of azathio- 
prine. In fact, analysis of the course of many 
patients appears to incriminate prednisonk 
specifically as the most important causative 
factor in the development of infection. Patients 
who require continuous large doses of prednisone 
to forestall rejection or who, faced with a late 
rejection, suddenly require a greatly increased 
dose are the ones who die of infection [16]. I t  
must be concluded that progress in therapy 
with nonspecific immunosuppression-using 
drugs of general toxicity to immune mechanisms 
-has reached an impasse. Further progress in 
reducing mortality must depend on other 
avenues. 
Is there a way out of this dilemma? Final suc- 
cess presumably awaits more complete elucida- 
tion of the nature of histocompatibility antigens, 
the corresponding genetic apparatus which de- 
termines these antigens and the development of 
rapid screening tests for them [17]. In the mean- 
time, it can be hoped that efforts now under way 
to provide a closer match of donor and recipient 
tissue antigens, or to provide more specific 
immunosuppression, will result in the need for 
less intense-general immunosuppressive meas- 
ures and less liability to infection [18j. One can 
attempt closer and closer antigen match of donor 
and recipient in the hope of avoiding offending 
antigens in the graft. Measures aimed specifi- 
cally at  suppressing graft rejection with minimal 
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effect on general protective mechanisms include 
the administration of antilymphocyte serum, 
extracorporeal lymphocyte radiation and tho- 
racic duct dialvsis. 
Antihuman lymphocyte globulin has been 
given a clinical trial as an adjuvant agent at 
these institutions in the period since the study 
reported herein was terminated. Antihuman 
lymphocyte globulin was prepared for intra- 
muscular injection from the serum of immu- 
nized horses. From June to December 1966 it 
was used in the treatment of twenty patients 
after renal transplantation, in accordance with 
guidelines derived from previous animal experi- 
ments. The antihuman lymphocyte globulin 
was added to therapy with azathioprine and 
prednisone, and its use restricted to the critical 
first four postoperative months. 
Nineteen of the patients are well; the only 
death resulted from a technical accident. Severe 
rejection has not been observed. The doses of 
azathioprine and prednisone used have been 
less than in any previous series of transplanta- 
tions at our institutions. There has been only 
one serious infectious com~lication in the series. 
Renal function in all ten of the patients who re- 
ceived a transplant more than three months ago 
is normal. 
The question of foreign protein toxicity was 
examined in these patients in collaboration with 
Drs. K. A. Porter, B. Seegal and G. Andres of 
London, New York and Rome, respectively. 
Delayed but definite increases in precipitin and 
antisheep red cell titers were regularly seen. 
~ e l a t i v e l ~  minor anaphyllactoid reactions oc- 
curred in three patients, which did not neces- 
sitate therapy in two. Homograft biopsy speci- 
mens obtained after 108 to 145 davs in the first 
eight cases were examined with conventional 
as well as labeled antibody technics. There was 
no equine protein in any of these eight homo- 
grafts, nor was there other evidence of "foreign 
protein nephritis." 
Developments such as these may lead to im- 
provement in the rate of infection, but in the 
meanwhile exhaustive efforts to diagnose infec- 
tion promptly must be made, and the clinician 
mustmaintain extraordinary alertness, especially 
when treating patients who require large doses 
of drugs. Organisms commonly considered non- 
pathogenic must be suspect. Cultures must be 
kept long enough to grow fungi, and tracheal 
aspirates should be stained routinely with 
methenamine silver for demonstration of fungi 
as well as pneumocystis. In many cases lung 
biopsy should be considered. During periods of 
particular danger, i.e., when drugs are needed 
in large doses, patients should be carefully 
shielded from environmental contaminants. 
In other series, staphylococci and other common 
pathogens have been frequently associated with 
death [79-211. The fact that only a few patients 
in this series succumbed to infection by common 
pathogens may perhaps be due to maintenance 
of an extraordinary degree of alertness, as these 
organisms were identified quite commonly 
[22,23] but the patients were treated vigorously 
and early. Although the full spectrum of the 
mixed infections was unrecognized in some cases, 
the site of infection and the causative organism 
were known prior to death in most cases. 
Nevertheless, therapy was ineffectual in the 
fatalities reported herein. 
Pancreatitis has been encountered not un- 
commonly in patients receiving transplants, 
and two patients with hemorrhagic pancreatitis 
at  death are included in this series. Many 
others had varying degrees of mild pancreatitis. 
This has been reported previously from this 
institution [77,24] and elsewhere [25]. Whether 
this was related to pretransplant uremia, drug 
therapy or immunologic damage remains prob- 
lematical. A study of this problem is in prepara- 
tion. 
Viral infections, although commonly diag- 
nosed, were probably present but undiagnosed 
in many other cases. One of the most interesting 
presumed viral diseases was hepatitis, which 
occurred in several patients but was the cause 
of death in only one patient examined at  autopsy 
at this center. In a second patient less severe 
acute hepatitis, demonstrated by serial biopsies, 
persisted for over six months. A third patient 
died elsewhere, reportedly of hepatitis. Whether 
this is infectious -or posttransfusion hepatitis, 
intensified or prolonged by drug therapy, or 
whether it is drug-induced hepatitis, remains 
speculative. Azathioprine is hepatotoxic to dogs 
[26] but histologic analysis of the liver in pa- 
tients who died after treatment with this drug 
has not supported the idea that it is hepatotoxic 
in man 1271. 
- A 
Herpes zoster occurred in eight patients, 
and was present at death in one; in each case 
it vursued a clinical course which was not un- 
usual, and was accompanied by a prompt rise in 
antibody titer [28]. 
The most common viral infection was due to 
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cytomegalovirus, diagnosed by its characteristic 
morphology, cultural studies and antibody titers 
[8,1 I]. Rarely was this organism thought to be 
related to a specific lesion, and in no case did it 
appear to be the primary cause of death. A 
recent report suggests that cytomegalovirus may 
occasionally cause death in transplanted pa- 
tients [29]. This opinion was based on the pres- 
ence of hyaline membranes and interstitial 
pneumonia. However, we have seen many cases 
with septa1 cell. hyperplasia, small lymphoid 
nodules, occasional hyaline membranes, in- 
terstitial edema and fibrosis, all of which are 
commonly found in the lungs during infections 
with a variety of viruses, even in lungs which were 
apparently devoid of cytomegalovirus or other 
identified viral agent. I t  is difficult to assign a 
direct cause-effect relationship of a specific 
virus to these abnormalities but we have assumed 
that the changes indicate an undiagnosed viral 
infection. Drug effects and immunologic injury 
clearly cannot be ruled out. 
We conclude from this analysis of the causes 
of death in 123 consecutive patients who re- 
ceived transplant~ that postoperative mortality 
has become almost negligible. However, this 
has focused attention all the more on the delicate 
problem facing the therapist: the measures 
which suppress immunologic rejection of the 
transplanted organ also affect adversely the 
defense mechanisms against infection. By far 
the most important cause of death in this series, 
accounting for more than 80 per cent of fatali- 
ties, was infection with unusual organisms not 
susceptible to conventional antibiotic therapy, 
occurring in patients whose need for large doses 
of steroids and immunosuppressive drugs dates 
to the early postoperative period. Recent efforts 
at reducing the need for immunosuppressive 
therapy, using antilymphocyte globulin, and 
other efforts to minimize immunologic dif- 
ferences between donor and host, may lead to 
considerable amelioration of this extremely vex- 
ing problem. 
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